141 related articles for article (PubMed ID: 8287597)
21. Effects of Rauscher leukaemia virus on the immune system in susceptible and resistant mouse strains.
Tóth FD; Karsai T; Váczi L
Acta Microbiol Acad Sci Hung; 1971; 18(4):271-8. PubMed ID: 4136204
[No Abstract] [Full Text] [Related]
22. Murine retrovirus induces defects in the function of dendritic cells at early stages of infection.
Gabrilovich DI; Patterson S; Harvey JJ; Woods GM; Elsley W; Knight SC
Cell Immunol; 1994 Oct; 158(1):167-81. PubMed ID: 8087863
[TBL] [Abstract][Full Text] [Related]
23. Distribution of Fv-4 resistant gene product in Friend leukemia virus-resistant Fv-4r mouse strain.
Kitagawa M; Aizawa S; Kamisaku H; Sado T; Ikeda H; Hirokawa K
Exp Hematol; 1996 Oct; 24(12):1423-31. PubMed ID: 8913289
[TBL] [Abstract][Full Text] [Related]
24. Induction of acute thrombocytopenia and infection of megakaryocytes by Rauscher murine leukemia virus reflect the genetic susceptibility to leukemogenesis.
Grau GE; Puthavathana P; Izui S; Lambert PH
J Exp Med; 1983 Mar; 157(3):1028-39. PubMed ID: 6833948
[TBL] [Abstract][Full Text] [Related]
25. Suppression of retrovirus-induced immunodeficiency disease (murine AIDS) by trimidox and didox: novel ribonucleotide reductase inhibitors with less bone marrow toxicity than hydroxyurea.
Mayhew CN; Mampuru LJ; Chendil D; Ahmed MM; Phillips JD; Greenberg RN; Elford HL; Gallicchio VS
Antiviral Res; 2002 Nov; 56(2):167-81. PubMed ID: 12367722
[TBL] [Abstract][Full Text] [Related]
26. Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection.
Knuschke T; Rotan O; Bayer W; Sokolova V; Hansen W; Sparwasser T; Dittmer U; Epple M; Buer J; Westendorf AM
Retrovirology; 2016 Apr; 13():24. PubMed ID: 27076190
[TBL] [Abstract][Full Text] [Related]
27. Rauscher leukemia as a model for studies of marrow transplantation therapy: results using syngeneic, allogeneic and hybrid donors.
Okunewick JP; Meredith RF; Brozovich BJ; Seeman PR; Schieb AL
Int J Cancer; 1979 Oct; 24(4):438-44. PubMed ID: 43293
[No Abstract] [Full Text] [Related]
28. Chemoprevention of retroviral infection: success is determined by virus inoculum strength and cellular immunity.
Ruprecht RM; Bronson R
DNA Cell Biol; 1994 Jan; 13(1):59-66. PubMed ID: 8286040
[TBL] [Abstract][Full Text] [Related]
29. A notable phenomenon recapitulated. A fusion product of a murine lymphoma cell and a leukemia virus-neutralizing antibody-producer host plasma cell formed spontaneously and secreting the specific antibody continuously.
Sinkovics JG
Acta Microbiol Immunol Hung; 2005; 52(1):1-40. PubMed ID: 15957233
[TBL] [Abstract][Full Text] [Related]
30. The presence of unique DNA sequences after viral induction of leukemia in mice. (RNA tumor virus-nucleic acid hybridization-insertion of viral DNA).
Sweet RW; Goodman NC; Cho JR; Ruprecht RM; Redfield RR; Spiegelman S
Proc Natl Acad Sci U S A; 1974 May; 71(5):1705-9. PubMed ID: 4525459
[TBL] [Abstract][Full Text] [Related]
31. Studies on the susceptibility of C57BL/6 mice to Rauscher virus. I. Properties of Rauscher virus-induced C57BL/6 lymphomas.
Ishimoto A; Maeda M
J Natl Cancer Inst; 1970 Feb; 44(2):361-8. PubMed ID: 11515078
[No Abstract] [Full Text] [Related]
32. Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation.
Zeis M; Uharek L; Glass B; Vosskötter W; Dreger P; Schmitz N; Steinmann J
Exp Hematol; 1998 Oct; 26(11):1068-73. PubMed ID: 9766447
[TBL] [Abstract][Full Text] [Related]
33. Granulopoiesis in "preleukemic" mice with anemia induced by Rauscher leukemia virus, variant a.
Broxmeyer HE; Koltun L; LoBue J; Fredrickson TN; Gordon AS
J Natl Cancer Inst; 1975 Nov; 55(5):1123-7. PubMed ID: 1107569
[TBL] [Abstract][Full Text] [Related]
34. Ecotropic murine leukemia viruses and exogenous mouse mammary tumor viruses are not essential for pristane-induced lupus.
Akaogi J; Nacionales DC; Kuroda Y; Reeves WH; Satoh M
Arthritis Rheum; 2003 Oct; 48(10):2990-2. PubMed ID: 14558108
[No Abstract] [Full Text] [Related]
35. Genetic control of myeloproliferation in BXH-2 mice.
Turcotte K; Gauthier S; Mitsos LM; Shustik C; Copeland NG; Jenkins NA; Fournet JC; Jolicoeur P; Gros P
Blood; 2004 Mar; 103(6):2343-50. PubMed ID: 14630819
[TBL] [Abstract][Full Text] [Related]
36. Facilitation of hematopoietic recovery by bone grafts with intra-bone marrow-bone marrow transplantation.
Song C; Hisha H; Wang X; Li Q; Li M; Cui W; Guo K; Okazaki S; Mizokami T; Kato J; Cui Y; Feng W; Zhang Y; Shi M; Inaba M; Fan H; Ikehara S
Immunobiology; 2008; 213(6):455-68. PubMed ID: 18514748
[TBL] [Abstract][Full Text] [Related]
37. [Submicroscopic features of cells in the microenvironment of hematopoietic development of virus-induced Rauscher leukemia].
Butenko ZA; Naumenko OI
Gematol Transfuziol; 1993 Jun; 38(6):29-33. PubMed ID: 8307271
[TBL] [Abstract][Full Text] [Related]
38. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
Wustrow TP; Good RA
Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
[TBL] [Abstract][Full Text] [Related]
39. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
Zeis M; Uharek L; Glass B; Gaska T; Gassmann W; Mueller-Ruchholtz W
Bone Marrow Transplant; 1994 Nov; 14(5):711-5. PubMed ID: 7889004
[TBL] [Abstract][Full Text] [Related]
40. Graft-versus-leukemia effect in allogeneic bone marrow transplantation in mice against several radiation-induced leukemias.
Aizawa S; Sado T; Kamisaku H; Nemoto K; Yoshida K
Bone Marrow Transplant; 1994 Feb; 13(2):109-14. PubMed ID: 8205078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
